SEC Form 4 · accession 0001209191-16-094260
Travere Therapeutics, Inc. · TVTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Aselage
Officer — Chief Executive Officer · Director
Period of report
Jan 27, 2016
Accepted (ET)
Jan 29, 2016 · 6:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001438533
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 27, 2016 | G | 3,000 | $0.00 | D | 305,756 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Gift of shares by the Reporting Person to his grandchildren.